ArticleOncotarget2018

Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma.

Kelly M BaileyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.